ARMP
Armata Pharmaceuticals, Inc.
There isn't enough reported data to score ARMP yet.
ARMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
ARMP's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
ARMP PE Valuation
ARMP has no meaningful PE right now: it lost money over the past year.
ARMP Forward outlook
There aren't enough analyst estimates for ARMP to show an outlook.
ARMP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.08 | -$5.89 |
| Q2 2026 | -$7.58 | -$6.98 |
| Q1 2026 | -$7.76 | -$7.36 |
| Q4 2025 | -$4.80 | -$3.91 |
| Q3 2025 | -$1.19 | +$0.38 |
| Q2 2025 | -$0.60 | +$1.68 |
| Q1 2025 | -$0.40 | +$1.80 |
| Q4 2024 | -$0.89 | +$1.02 |
ARMP lost $7.08 per share over the past year, a bigger loss than the year before.
ARMP Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2020 | -14806% | N/A |
ARMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.6M | -$1.1M |
| Q2 2026 | -$8.7M | -$1.3M |
| Q1 2026 | -$5.8M | +$1.8M |
| Q4 2025 | -$6.7M | +$1.1M |
| Q3 2025 | -$4.5M | +$4.7M |
| Q2 2025 | -$7.4M | +$4.2M |
| Q1 2025 | -$7.7M | +$3.2M |
| Q4 2024 | -$7.9M | +$2.7M |
ARMP has burned cash in almost every quarter: −$27M over the past year, against −$27M the year before.
ARMP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +638K shares |
| 1 year | +73% | +26.5M shares |
| 3 years | +11% | +6.1M shares |
| 5 years | +206% | +42.2M shares |
ARMP has 63M diluted shares, up 73% from a year ago.
ARMP Net Leverage
ARMP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.2 | Neutral |
| Stochastic | 19.5 | Oversold |
ARMP's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).
ARMP PE vs Healthcare Sector
ARMP has no meaningful PE right now: it lost money over the past year.
ARMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.55 | 4.8% above |
| 20 week MA | $4.37 | 15% below |
| 50 week MA | $6.69 | 44% below |
| 100 week MA | $4.67 | 20% below |
| 200 week MA | $3.61 | 3% above |
ARMP's trend is mixed: it's above two of its five weekly moving averages, and 3% above its 200-week average.
ARMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.23 | $2.89 | -11% |
| 2021 | $2.89 | $5.66 | +96% |
| 2022 | $5.66 | $1.29 | -77% |
| 2023 | $1.29 | $3.24 | +151% |
| 2024 | $3.24 | $2.11 | -35% |
| 2025 | $2.11 | $6.58 | +212% |
| 2026 YTD | $6.58 | $3.72 | -43% |
ARMP's yearly returns have swung widely, from +212% in 2025 to −77% in 2022. It's down 43% so far in 2026.